Prescription Required(Save Upto 40%)
Imfinzi 120mg injection is an anticancer drug belonging to the class of Anti-PD-1 monoclonal antibodies, containing the active ingredient Durvalumab.
This medicine is administered through intravenous injection by your doctor or nurse. This medicine is given when cancer has spread in other areas of your body or cannot be removed by surgery. Take this injection as prescribed by your medical advisor. Do not stop the use of dosage without taking permission from your doctor.
This drug is often used in combination with carboplatin or cisplatin for the treatment of small-cell lung cancer and also used in combination with gemcitabine for the treatment of biliary tract cancer.
Report to your doctor if you have been diagnosed with kidney disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment.
Before taking it, tell your doctor if you have heart disease, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.
It works by blocking a protein called programmed death-ligand 1 (PD-L1), which is found on the surface of certain cancer cells. When PD-L1 binds to its receptor on T cells, it can inhibit the immune system's ability to recognize and attack cancer cells.
By blocking the interaction between PD-L1 and its receptor, this drug allows T cells to recognize and attack cancer cells more effectively. It helps the immune system to fight cancer and potentially slow or stop its growth.
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ans : Imfinzi 120mg injection is administered intravenously into a vein in your arm or hand by a healthcare professional.
Ans : It works by blocking a protein called programmed death-ligand 1 (PD-L1), which is found on the surface of certain cancer cells. When PD-L1 binds to its receptor on T cells, it can inhibit the immune system's ability to recognize and attack cancer cells. By blocking the interaction between PD-L1 and its receptor, this drug allows T cells to recognize and attack cancer cells more effectively. It helps the immune system to fight the cancer and potentially slow or stop its growth.
Ans :Yes, Imfinzi 120mg injection is often used in combination with other immunotherapy drugs, such as tremelimumab, to boost the immune response against cancer cells.
Ans : Imfinzi 120mg injection is not recommended during pregnancy and it is unsafe because it may harm a developing fetus. Women who are pregnant or planning to become pregnant should discuss their treatment options with their doctor immediately.
Ans : Imfinzi 120mg injection is not recommended in patients with autoimmune diseases, such as lupus, rheumatoid arthritis, or multiple sclerosis, who may be at an increased risk of side effects from drug, and it should be used with caution in these patients.
